Global Initiative for Chronic Obstructive Lung Disease (GOLD)

Keywords

Medicine, Obstructive lung disease, Pulmonary disease, Lung disease, Internal medicine

References

• FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohortsÀlvar Agustí, Suzanne S. Hurd, Paul Jones — 2013
• Chronic obstructive pulmonary disease: current burden and future projectionsAlan D López, Kenji Shibuya, Chalapati Rao — 2006
• COPD management according to old and new GOLD guidelines: an observational study with Italian general practitionersSara Maio, Sandra Baldacci, Franca Martini — 2014
• Global burden of COPD: systematic review and meta-analysisRonald J. Halbert, Jaime L. Natoli, Anacleto D. Gano — 2006
• Neurological Disorders: Public Health ChallengesGideon Vardi, Joav Merrick — 2007
• Chronic Obstructive Pulmonary Disease in Non-Smokers.Núria Toledo-Pons, Borja G. Cosío, M. del Valle Velasco — 2017

Cited by

• Antibiotic Treatment of Severe Exacerbations of Chronic Obstructive Pulmonary Disease with Procalcitonin: A Randomized Noninferiority TrialMaría Victoria Martín — 2015
• Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary diseaseSeigo Minami, Yu Nishijima, Suguru Yamamoto — 2015
• Early chronic obstructive pulmonary disease: definition, assessment, and prevention太郎 田口, 春彦 後藤, 義人 山崎 — 2015
• Do preoperative pulmonary function indices predict morbidity after coronary artery bypass surgery?Карташов Лев Петрович, Ушаков Юрий Андреевич, Василевский Георгий Петрович — 2015
• A summary of the new GINA strategy: a roadmap to asthma controlМанчурина Лидия Егоровна — 2015
• Vasoactive Intestinal Peptide for Diagnosing Exacerbation in Chronic Obstructive Pulmonary DiseaseJyotshna Mandal, Michael Roth, Luigi Costa — 2015
• Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trialMohit Tiwari, Prashanth Mohan, Andrew Osheroff — 2015
• COPD: Evidence-based medicine or the patient-centered medicine?António Araújo — 2016
• Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain.Juan José Soler‐Cataluña, Jaume Sauleda, Luís Valdés — 2016
• Prevalence of Airflow Limitation Defined by Pre- and Post-Bronchodilator Spirometry in a Community-Based Health Checkup: The Hisayama Study.Quim Casas — 2016
• Incidence, Predictors, and Clinical Implications of Discontinuing Therapy with Inhaled Long-Acting Bronchodilators among Patients with Chronic Obstructive Pulmonary DiseaseJoaquín Cortés José — 2016
• Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysisLinda Grass, Robert D. Kreger — 2016
• Clinical implications of blood eosinophil count in patients with non-asthma–COPD overlap syndrome COPDElena F. Pérez Carrillo — 2017
• Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow LimitationTejas Shah, Pega Hrnjak — 2017
• Predictors of short-term LAMA ineffectiveness in treatment naïve patients with moderate to severe COPDJames Baird Nelson — 2018
• Mobility limitations related to reduced pulmonary function among aging people with chronic obstructive pulmonary diseaseRafael Savi — 2018
• Comparison of clinical scores in their ability to detect hypoxemic severe OSA patientsE.W. Metters — 2018
• Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operationE. George Robison — 2018
• A prospective study of salvational intervention with ICS/LABA for reducing chronic obstructive pulmonary disease exacerbation under severe air pollution (SIRCAP) in Beijing: protocol of a multi-center randomized controlled trial洋 三好 — 2019
• Evaluating fluticasone furoate + vilanterol for the treatment of chronic obstructive pulmonary disease (COPD)Andrew Roberts Cummings — 2019

Related papers

• ИСТОРИЧЕСКОЕ РАЗВИТИЕ КЛАССИФИКАЦИИ ХРОНИЧЕСКОЙ ОБСТРУКТИВНОЙ БОЛЕЗНИ ЛЕГКИХА В Никитин, L. V. Vasilyeva, Е. П. Карпухина — 2018
• Lung biology and lung diseaseJohn S. Torday — 2011
• Targeting maladaptive glutathione responses in lung diseaseNeal S. Gould, Brian J. Day — 2010
• Spirometric References Values in Five Canadian Cities for Subjects 40 Years and Older: Results From the Canadian Obstructive Lung Disease (COLD) StudyWan C. Tan, Daniel Chen, Jean Bourbeau — 2010
• Chronic Obstructive Lung DiseasesChristopher M. Stafford, Dennis E. Amundson — 2002
• COMING TO THE AID OF CHRONIC OBSTRUCTIVE LUNG DISEASE WITH ALMITRINE1983